	Ebitda		Date
Acadia Pharmaceuticals	USD 35.76M	447K	2025-09
Agios Pharmaceuticals	USD -115.49M	10.3M	2025-09
Alnylam Pharmaceuticals	USD 145.22M	236.56M	2025-12
BioMarin Pharmaceutical	USD -5.26M	300.71M	2025-09
Esperion Therapeutics	USD -27.51M	9.5M	2023-09
Immunic	USD -22.78M	753K	2024-06
Insmed	USD -314.19M	31.48M	2025-12
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
Karyopharm Therapeutics	USD -26.2M	1.83M	2024-09
Kyowa Hakko Kirin	JPY 45.74B	13.46B	2025-12
MacroGenics	USD 21.95M	55.39M	2025-09
Moderna	USD -790M	582M	2025-12
Neurocrine Biosciences	USD 218.4M	28.3M	2025-12
PTC Therapeutics	USD 20.63M	53.74M	2025-09
Puma Biotechnology	USD 729K	11.36M	2024-06
Regeneron Pharmaceuticals	USD 1.92B	261.9M	2025-09
Sarepta Therapeutics	USD -168.03M	294.45M	2025-09
Ultragenyx Pharmaceutical	USD -156.79M	65.44M	2025-09
Vertex Pharmaceuticals	USD 1.44B	100.4M	2025-09
Xoma	USD 2.52M	7.98M	2024-06

Ultragenyx Pharmaceutical - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.